Table 4 Palliative hormone therapy, according to age group
Hormonal treatment | Age at time of diagnosis of primary tumor | |||
|---|---|---|---|---|
|  | 20–49 (n = 28) | 50–69 (n = 54) | 70+ (n = 16) | total (n = 98) |
Total number of courses | 70 | 112 | 34 | 216 |
Drug | ||||
   tamoxifen | 27 | 35 | 8 | 70 |
   aromatase inhibitor | 21 | 40 | 11 | 72 |
   megestrol acetate | 13 | 24 | 8 | 45 |
   other | 9 | 13 | 7 | 29 |
Response | ||||
   yes* | 7 | 28 | 3 | 38 |
   no (progressive disease) | 63 | 82 | 31 | 176 |